วันพฤหัสบดีที่ ๓๐ มีนาคม พ.ศ. ๒๕๖๐ ๐๒:๐๐ น.
Food and Healthcare Press Releases
Bangkok Hospital Pattaya in cooperation with Queen Savang Vadhana Memorial Hospital (Somdej Pra Boromrajthevi na Sriracha) and the Thai Red Cross Society, have combined for another Blood Donation project. On Thursday 23rd March 2017 from 9.30 a.m.
Today, Novo Nordisk announced that Fiasp(R), a new, fast-acting mealtime insulin for the treatment of diabetes in adults, has been launched in Canada, following the recent marketing authorisation from Health Canada on 6 January 2017.
Fiasp(R) is insulin aspart in an innovative formulation that more closely matches the natural physiological insulin response of a person without diabetes after a meal, compared with NovoRapid(R) (conventional insulin aspart). Fiasp(R) also has the option of a flexible dosing regimen (up to 20 minutes after starting a meal), without compromising overall glycaemic control, when compared to NovoRapid(R) dosed at mealtime ,.
"The launch of Fiasp(R) in Canada represents the first new mealtime insulin in 10 years. We hope to make this innovation available to as many people with diabetes as possible worldwide," said Mads Krogsgaard Thomsen, executive vice president and chief science officer of Novo Nordisk. "The goal of any insulin treatment is to match the natural physiological insulin production we see in people without diabetes, both in speed and glyc
- Only FDA-approved treatment for metastatic Merkel cell carcinoma, a rare and aggressive skin cancer - First indication for BAVENCIO, a human anti-PD-L1 antibody Merck and Pfizer Inc. (NYSE: PFE) today announced that the US Food and Drug Administration
The Golisano Foundation and Special Olympics, the largest public health organization for people with intellectual disabilities (ID), honored the Rajanukul Institute, Ministry of Public Health, Thailand in Bangkok, Thailand for launching a national health
Today on World Oral Health Day , FDI World Dental Federation is myth busting what people around the world believe to be good oral health practices, encouraging them to become better informed and take action. Oral health is integral to our general health
International Society for Applied Biological Sciences (ISABS), Mayo Clinic และ St. Catherine Hospital ร่วมด้วย Philips เตรียมจัดการประชุม "The Tenth ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized
International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital in partnership with Philips are organizing "The Tenth ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized
HIMSS Asia Pacific ประกาศผนึกกำลังกับ Singapore Nurses Association (SNA) และ Integrating the Health Enterprise (IHE) จัดกิจกรรมที่น่าสนใจทั้งก่อนและระหว่างการประชุม HIMSS AsiaPac17 ซึ่งจะจัดขึ้นระหว่างวันที่ 11-14 กันยายนนี้ ณ โรงแรม Marina Bay Sands
HIMSS Asia Pacific announced today that it will be joining forces with Singapore Nurses Association (SNA) and Integrating the Health Enterprise (IHE) to offer pre-conference and main conference programs for delegates at this year's HIMSS AsiaPac17
- Merck integrates innovative Eeva(R) Test with Geri(TM) incubation platform, bringing individualized incubation and outcome prediction together - Geri(TM) humidity technology aims to further advance incubation to precisely monitor and manage the
The Dr. Guislain Museum in Ghent, Belgium and Janssen Research & Development, LLC ("Janssen"), today announced that they are seeking nominations for the sixth annual Dr. Guislain "Breaking the Chains of Stigma" Award. The Award honors an individual,
LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to severe atopic dermatitis (AD), a serious and chronic form of eczema. Tralokinumab is an investigational
- More patients now able to receive a standard-of-care treatment with Erbitux plus FOLFIRI or FOLFOX - NICE's recommendation is a significant step forward in Merck's aspiration to ensure cancer patients have optimal access to effective treatments
- Prognosis for urothelial carcinoma is currently poor, particularly when the disease has metastasized Merck and Pfizer Inc. today announced that the US Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License
ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF) today announced that for the first time, allergy immunotherapy is now recommended as a treatment option in the Global Initiative for Asthma (GINA) report: Global Strategy for Asthma Management and Prevention.
Mederi Therapeutics เผยผลการวิเคราะห์ข้อมูลจากการวิจัย 28 โครงการ ครอบคลุมผู้ป่วยโรคกรดไหลย้อน 2,468 คนที่เข้ารับการรักษาด้วย Stretta Therapy โดยผลการวิเคราะห์ในหัวข้อ " Systematic Review and Meta-Analysis of Controlled and Prospective Cohort Efficacy
Mederi Therapeutics today announced the publication of a meta-analysis of 28 studies, representing 2468 patients who received Stretta Therapy to treat gastroesophageal reflux disease (GERD). The study entitled, " Systematic Review and Meta-Analysis of
- Simplified injection device for self-administration comes in multiple doses, addressing individual needs of patients Merck, a leading science and technology company, today announced that the European Committee for Medicinal Products for Human Use
Tillotts Pharma is strengthening its presence in the German market: the Berlin office was opened in January 2017 under the management of Magdalena Kritikos. The portfolio includes Entocort(R) for the treatment of Crohn's disease, Asacol(R) for the
World renowned dermatologist, Dr. Lancer was honored with the 'Beauty Enhancement Award' for his pioneering approach to dermatology and in recognition of his unrivalled relationships with his patients all over the world. The black tie dinner gala,
At the University Hospital Basel all patient information is stored digitally in the hospital's data center. It is essential that the facility's electrical infrastructure is the best that it can be – lives depend on it. The hospital decided to
60 years after the market launch of Contergan (active ingredient: thalidomide), the greatest pharmaceutical scandal in the Federal Republic of Germany continues to boil. A lawsuit will be heard in the Bonn Regional Court at 12:00 hrs on 15.2.2017 that is
- First Detailed Results from SWORD Clinical Trial Program Show Investigational Two-drug Combination as Effective as Three- or Four-drug Regimens as Maintenance Therapy in Patients who have Already Achieved Viral Suppression Janssen Sciences Ireland UC
Baricitinib, marketed as Olumiant, is the first JAK inhibitor approved to treat RA in the EU Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) announced today that the European Commission has granted marketing authorisation for